Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New cephem antibacterial agents from Takeda

Jan. 30, 1997

Schering-Plough claims tetrahydrofuran antifungal agents

Jan. 30, 1997

Voriconazole effective in guinea pig model of A. fumigatus endocarditis

Jan. 28, 1997

Mediolanum prepares novel quinolone antibacterial agents

Jan. 28, 1997

Spotlight on influenza sialidase inhibitors

Jan. 28, 1997

Roche presents new antifungal agents

Jan. 24, 1997

Antifungal echinocandin derivatives reported by Lilly

Jan. 24, 1997

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Drug screening technology available for licensing

Jan. 22, 1997

n-Docosanol efficacy demonstrated in herpes labialis

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...